Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 3/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28254598 | 0.92 | USP2 (0.53) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL19257794 | 0.88 | USP2 (0.74) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL9330015 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL21187461 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL4295700 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL11230218 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL1629995 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL10893424 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL7644994 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL10511992 | 0.86 | USP2 (0.71) | USP2HTTLPAR5CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3250177-A1 | HAIR TREATMENT COMPOSITION | Lonza Ltd (CH) | 2017-12-06 | — | — | EP | disclosed |
| WO-2016120851-A1 | HAIR TREATMENT COMPOSITION | LONZA LTD. (CH) | 2016-08-04 | — | — | WO | disclosed |
| US-20110089073-A1 | Methods And Compositions For Hydrophobic Modification Of Oral Cavity Surfaces | THE PROCTER & GAMBLE COMPANY (US) | 2011-04-21 | — | — | US | disclosed |
| US-5632998-A | Personal care compositions containing hydrophobic graft copolymer and hydrophobic, volatile solvent | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110089073-A1 | Methods And Compositions For Hydrophobic Modification Of Oral Cavity Surfaces | PTMS, TAS2R39, CASP3 | USP2 1599/4885HTT 1126/4885LPAR5 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.